Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA’s Rare Pediatric Voucher Program Faces Tight Deadline For Reauthorization
Sep 25 2024
•
By
Sue Sutter
The rare pediatric disease PRV program is scheduled to start sunsetting on 1 October.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Review Pathways
More from United States